PR Stories

Manjeet Rao, PhD in his lab

Manjeet Rao, PhD, Awarded NCI, R01 Grant to Test Efficacy of Novel Drug

February 25, 2020

Dr. Manjeet Rao, Greehey CCRI Deputy Director (interim), was recently awarded a grant from National Cancer Institute ($2.1 million) to test the therapeutic efficacy of a novel drug that can inhibit the function of a protein that is highly expressed in cancers. Cancer cells use various mechanisms to manage their survival such as repairing DNA […]

Rao & Gupta

Greehey CCRI Faculty Awarded $1.2M CPRIT Grant to Support Osteosarcoma Research

February 24, 2020

Written by: Will Sansom An award of $1.2 million from the Cancer Prevention and Research Institute of Texas (CPRIT) went to Greehey CCRI Deputy Director and principal investigator Manjeet Rao, PhD, professor of cell systems and anatomy, for studies of an enzyme protein that helps osteosarcoma cells to survive and spread.  The team, which includes co-principal investigator Yogesh Gupta, […]

Pipette Gazette: Kevin Kanda, From Nursing Student To Graduate Student (Bishop Lab)

February 20, 2020

Kevin Kanda made a promise to his family to try to fight cancer. “I’ve lost some family and friends to cancer….my uncle died from lymphoma and I’ve known people with pancreatic and breast cancer as well,” he said. Initially, Kanda thought nursing would be a good option for him. He tried nursing school for a […]

San Antonio Business Journals: San Antonio lands one of its largest cancer grant allocations ever to bring in more talent

February 20, 2020

CPRIT officials said this is one of the largest collective awards the Alamo City has received in a single funding round.

Cell Stem Cell: Zika virus targets glioblastoma stem cells through a SOX2-integrin αvβ5 axis

February 6, 2020

Zhe Zhu, Pinar Mesci, Jean A Bernatchez, Ryan C Gimple, Xiuxing Wang, Simon T Schafer, Hiromi I Wettersten, Sungjun Beck, Alex E Clark, Qiulian Wu, Briana C Prager, Leo JY Kim, Rekha Dhanwani, Sonia Sharma, Alexandra Garancher, Sara M Weis, Stephen C Mack, Priscilla D Negraes, Cleber A Trujillo, Luiz O Penalva, Jing Feng, Zhou […]

Adam Kosti Publishes First, First-Author Paper (Penalva Lab)

January 10, 2020

ELF4 is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State Abstract 13-Cis-retinoic acid (RA) is typically used in postremission maintenance therapy in patients with neuroblastoma. However, side effects and recurrence are often observed. We investigated the use of miRNAs as a strategy to replace RA as promoters of differentiation. miR-124 was identified […]

Frontiers in Biosciences (Elite Ed) Cytogenetics of hepatoblastoma

January 2, 2020

Gail E Tomlinson 1 Abstract The cytogenetics of hepatoblastoma demonstrate recurring events which include whole chromosome trisomies, most commonly trisomy of chromosome 2, 8, or 10. In addition, unbalanced translocations involving a breakpoint on the proximal short arm of chromosome 1 are observed which results in a duplication of the long arm of chromosome 1q. The […]

San Antonio Magazine: Top Doctors

January 1, 2020

Professor of Pediatrics, Greehey distinguished chair in genetics and cancer; division director, pediatric hematology-oncology; co-director, population science and prevention program, Mays Cancer Center/UT Health When Dr. Gail Tomlinson decided to specialize in pediatric oncology and hematology, she saw it as a way to ensure she was always learning while still making a direct impact on […]

GRACIAS Texas: Empowering South Texas’ underserved population (Tomlinson)

December 26, 2019

Senior health educator Anna Maria Pulido Saldivar, who is based in Laredo, educates community members in South Texas about cancer prevention and screening. Mays Cancer Center Annual Report Knowledge is power, and with today’s advances in science, knowing the family history of cancer through genetic testing can save lives. For millions of underserved minority populations, […]

Technology News Network: Team Develop Drugs To Fight Leukemia and Lymphoma

December 9, 2019

UT Health San Antonio researchers, working with collaborators at the University of Florida, have discovered a safe and potent next generation of drugs to fight multiple types of leukemia and lymphoma in adults and children. The journal Nature Medicine reported the findings Dec. 2. “This is a new class of drugs called PROTACs that target […]